The FDA issued a warning letter to Novo Nordisk for failing to report serious adverse events linked to Ozempic, Wegovy, and Saxenda. Investigators cited systemic failures in reporting strokes, suicides, and deaths.
Posts tagged as “GLP-1 drugs”
A federal court has consolidated more than 70 lawsuits alleging Ozempic, Wegovy, and similar drugs caused partial or permanent vision loss. The cases will proceed as a new multidistrict litigation separate from existing lawsuits over severe gastrointestinal injuries.
More than 13.5 million people now take weight-loss injections, and the list of potential side effects is growing. Patients and doctors are seeing an increase…